This study was designed to compare the effect of [des-Aspartyl1]-angiotensin II ([des-Asp]-A II) and angiotensin II (A II) on blood pressure and aldosterone production in man under conditions of normal and low sodium (Na) intake. Seven normal male subjects in balance on constant normal Na intake (UNa V 160.3±5.0 meq/24 h) for 5 days received A II and [des-Asp]-A II infusions on two consecutive days; 1 mo later they were restudied after 5 days of low Na intake (UNa V 10.5±1.6 meq/24 h). Each dose was infused for 30 min, sequentially. During normal Na intake, [des-Asp]-A II from 2 to 18 pmol/kg per min increased mean blood pressure from 85.2±3 to 95.3±5 mm Hg and plasma aldosterone concentration from 5.2±1.1 to 14.3±1.9 ng/100 ml. During low Na intake, the same dose of [des-Asp]-A II increased mean blood pressure from 83.7±3 to 86.7±3 mm Hg and plasma aldosterone concentration from 34.4±6.0 to 51.0±8.2 ng/100 ml. In contrast, A II from 2 to 6 pmol/kg per min during normal Na intake increased mean blood pressure from 83.3±4 to 102.3±4 mm Hg and plasma aldosterone concentration from 7.0±2.2 to 26.8±2.0 ng/100 ml; during low Na intake, A II increased mean blood pressure from 83.0±3 to 96.0±4 mm Hg and plasma aldosterone concentration from 42.0±9.7 to 102.2±15.4 ng/100 ml. A II and [des-Asp]-A II were equally effective in suppressing renin release. Plasma cortisol and Na and K concentration did not change.
Robert M. Carey, E. Darracott Vaughan Jr., Michael J. Peach, Carlos R. Ayers
Title and authors | Publication | Year |
---|---|---|
The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
XC Li, J Zhang, JL Zhuo |
Pharmacological Research | 2017 |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Angiotensin Antagonists
MJ Robertson |
Journal of Receptors and Signal Transduction | 2000 |
Angiotensin-(1–7): a bioactive fragment of the renin–angiotensin system1100 years of Renin.1
CM Ferrario, SN Iyer |
Regulatory Peptides | 1998 |
Angiotensin and Blood Pressure Regulation
FA Mendelsohn, R Quirion, AM Allen, G Aguilera, MA Millan, KJ Catt |
Angiotensin and Blood Pressure Regulation | 1998 |
Angiotensin II Has Depressor Effects in Pregnant and Nonpregnant Women
FB Pipkin, PN Baker |
Hypertension | 1997 |
Effects of atrial natriuretic peptide and angiotensin III on the uptake and intracellular distribution of norepinephrine in medulla oblongata of the rat
MS Vatta, LG Bianciotti, ML Papouchado, AS Locatelli, BE Fernández |
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology | 1991 |
Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans
NV Ragsdale, M Lynd, RL Chevalier, RA Felder, MJ Peach, RM Carey |
Hypertension | 1990 |
Medical Treatment of Low-Renin Aldosteronism
Y Shenker |
Endocrinology and metabolism clinics of North America | 1989 |
Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors
C Lombardi, C Missale, RD Cotiis, C Spedini, G Pizzoccolo, M Memo, A Albertini, PF Spano |
European Journal of Clinical Pharmacology | 1988 |
The Adrenal Gland
CR Kannan |
1988 | |
Proceedings of the 1985 Laurentian Hormone Conference
RM Carey, S Sen |
Proceedings of the 1985 Laurentian Hormone Conference | 1986 |
Relative biological activities of Asn1-, Val5-angiotensin II, Ile5-angiotensin II and Sar1-angiotensin II in man
T Kono, A Taniguchi, H Imura, F Oseko, MC Khosla |
Life Sciences | 1985 |
Identification of the angiotensin II receptor in rat mesenteric artery
J McQueen, GD Murray, PF Semple |
Biochemical Journal | 1984 |
Idiopathic Hyperaldosteronism: A Possible Role for Aldosterone-Stimulating Factor
RM Carey, S Sen, LM Dolan, CD Malchoff, FM Bumpus |
New England Journal of Medicine | 1984 |
Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: Differential responses during sodium loading and depletion
CR Drake, NV Ragsdale, DL Kaiser, RM Carey |
Metabolism | 1984 |
Cytochemical Bioassays
JC Jones, J Alaghband-Zadeh, GA MacGregor |
Cytochemical Bioassays | 1983 |
Biological activity of des-(Asp1, Arg2, Val3)-angiotensin II in man
T Kono, F Oseko, F Ikeda, R Nakano, A Taniguchi, H Imura, MC Khosla |
Life Sciences | 1983 |
Mineralocorticoids and Hypertension
W Kaufmann, G Wambach, A Helber, KA Meurer |
1983 | |
Effects of Angiotensin III and Acth on Aldosterone Secretion
PG Zager, JA Luetscher, PG Zager, JA Luetscher |
Clinical and Experimental Hypertension | 1982 |
Angiotensin II receptors on human platelets
TJ Moore, GH Williams |
Circulation research | 1982 |
Regulation of vascular angiotensin II receptors in the rat during altered sodium intake
G Aguilera, K Catt |
Circulation research | 1981 |
[DES-ASP1] angiotensin II in the sheep: Blood levels and its effect on plasma renin concentration
DT Fei, WF Graham, JG McDougal, BA Scoggins, JP Coghlan |
Life Sciences | 1980 |
A comparison of angiotensin II and angiotensin III as vasoconstrictors in the mesenteric circulation of dogs
SL Britton, JM Sexton, MJ Fiksen-Olsen, PG Werness, JC Romero |
Circulation research | 1980 |
Activity of [des-Aspartyl1]-Angiotensin II in Primary Aldosteronism
RM Carey, CR Ayers, ED Vaughan, MJ Peach, SM Herf |
Journal of Clinical Investigation | 1979 |
Response of adrenal steroids to angiotensin II in essential hypertension
U Yasuhisa, H Masanobu, H Michinobu |
Journal of Steroid Biochemistry | 1979 |
The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man
JM Vinci, D Horwitz, RM Zusman, JJ Pisano, KJ Catt, HR Keiser |
Hypertension | 1979 |